Home/Bills/S 7807New York · 2025–2026 Legislative Session
Senate BillChaptered/Signed

S 7807: Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.

New York · Senate · 2025–2026 Legislative Session · last verified November 12, 2025

What S 7807 does, verified November 12, 2025

The bill expands the definition of epinephrine devices to include epinephrine nasal sprays. Eligible individuals and entities, such as schools, sports teams, and entertainment venues, can purchase, possess, and use epinephrine devices for emergency treatment of anaphylactic symptoms. These individuals must complete training in the use of epinephrine devices and designate someone to oversee the devices. Healthcare practitioners can prescribe and provide epinephrine devices, and pharmacists can dispense them. The use of epinephrine devices is considered first aid or emergency treatment for liability purposes. Places of public assembly are required to maintain and make available on-site epinephrine devices.<br>The bill aims to ensure the availability of epinephrine auto-injector devices in public places, schools, and other locations where individuals with severe allergies may be present. P…

Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: SIGNED CHAP.502 (2025-11-12)Alert me
Quick answers about S 7807
What is the current status of S 7807?
As of November 12, 2025, S 7807 is recorded as "Chaptered/Signed": it has been signed by the Governor and chaptered into law. The last recorded action, on November 12, 2025, was "SIGNED CHAP.502".
Did S 7807 pass?
Yes. S 7807 passed both houses and was signed into law (last action November 12, 2025). New York laws take effect on the date written into the bill, often immediately on signing or a set number of days afterward.
Who wrote S 7807, and where is it now?
S 7807 was authored by Sen. Andrew Gounardes with 4 coauthors.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlock
Coauthors
Cordell CleareSamra BroukPeter OberackerGustavo Rivera
Recent actions14 total · showing 5
Nov. 12, 2025SIGNED CHAP.502
Nov. 03, 2025DELIVERED TO GOVERNOR
Jun. 12, 2025returned to senate
Jun. 12, 2025passed assembly
Jun. 12, 2025ordered to third reading rules cal.318
Full action history, 9 earlier actionsConnect Plus
Latest bill textIntroduced version, May 9, 2025 · 3,458 words
  
  STATE OF NEW YORK ________________________________________________________________________ 7807 2025-2026 Regular Sessions  IN SENATE May 9, 2025 ___________ Introduced by Sen. GOUNARDES -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the education law, in relation to expanding the definition of epinephrine devices to include epineph- rine nasal sprays The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 3000-c of the public health law, as amended by 2 chapter 373 of the laws of 2016, paragraph (a) of subdivision 1 as 3 amended by chapter 472 of the laws of 2024, and paragraph (f) of subdi- 4 vision 2 as amended by chapter 373 of the laws of 2016, is amended to 5 read as follows: 6 § 3000-c. Epinephrine [auto-injector] devices. 1. Definitions. As used 7 in this section: 8 (a) "Eligible person or entity" means: (i) an ambulance service or 9 advanced life support first response service; a certified first respon- 10 der, firefighter in a county, city, town or village having a population 11 of less than two million provided such county is not wholly located 12 within a city with a population of more than one million, emergency 13 medical technician, or advanced emergency medical technician, who is 14 employed by or an enrolled member of any such service; (ii) a children's 15 overnight camp as defined in subdivision one of section thirteen hundred 16 ninety-two of this chapter, a summer day camp as defined in subdivision 17 two of section thirteen hundred ninety-two of this chapter, a traveling 18 summer day camp as defined in subdivision three of section thirteen 19 hundred ninety-two of this chapter or a person employed by such a camp; 20 (iii) a school district, board of cooperative educational services, 21 county vocational education and extension board, charter school, and 22 non-public elementary and secondary school in this state or any person 23 employed by any such entity, or employed by a contractor of such an 24 entity while performing services for the entity; (iv) a sports, enter- EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09090-03-5 

 S. 7807 2 1 tainment, amusement, education, government, day care or retail facility; 2 an educational institution, youth organization or sports league; an 3 establishment that serves food; or a person employed by such entity; (v) 4 a police officer or peace officer in a county, city, town or village 5 having a population of less than two million provided such county is not 6 wholly located within a city with a population of more than one million; 7 (vi) forest rangers, park rangers and environmental conservation police 8 officers; and (vii) any other person or entity designated or approved, 9 or in a category designated or approved pursuant to regulations of the 10 commissioner in consultation with other appropriate agencies. 11 (b) "Epinephrine [auto-injector] device" means [a single-use] an 12 epinephrine delivery device or product approved by the federal food and 13 drug administration and used for the automatic injection or adminis- 14 tration of a premeasured dose of epinephrine into the human body for the 15 purpose of emergency treatment of a person appearing to experience 16 anaphylactic symptoms approved by the food and drug administration. 17 (c) "Health care practitioner" means a health care practitioner 18 licensed, certified, or authorized to practice under title eight of the 19 education law who is authorized thereby to administer drugs, and who is 20 acting within the scope of [his or her] such health care practitioner's 21 practice. 22 2. Possession and use. (a) Any eligible person or entity may purchase, 23 acquire, possess and use epinephrine [auto-injector] devices for emer- 24 gency treatment of a person appearing to experience anaphylactic symp- 25 toms, under this section. 26 (b) An eligible person or entity shall designate one or more individ- 27 uals who have completed the training required by paragraph (c) of this 28 subdivision to be responsible for the storage, maintenance, control, and 29 general oversight of the epinephrine [auto-injectors] devices acquired 30 by the eligible person or entity. 31 (c) No one may use an epinephrine [auto-injector] device on behalf of 32 an eligible person or entity unless [he or she has] they have success- 33 fully completed a training course in the use of epinephrine [auto-injec- 34 tor] devices conducted by a nationally recognized organization experi- 35 enced in training laypersons in emergency health treatment or by an 36 entity or individual approved by the commissioner, or is directed in a 37 specific instance to use an epinephrine [auto-injector] device by a 38 health care practitioner. The training required by this paragraph shall 39 include (i) how to recognize signs and symptoms of severe allergic 40 reactions, including anaphylaxis; (ii) recommended dosage for adults and 41 children; (iii) standards and procedures for the storage and adminis- 42 tration of an epinephrine [auto-injector] device; and (iv) emergency 43 follow-up procedures. 44 (d) This section does not prohibit the use of an epinephrine [auto-in- 45 jector] device (i) by a health care practitioner or (ii) by a person 46 acting pursuant to a lawful patient-specific prescription. 47 (e) Every eligible person and entity authorized to possess and use 48 epinephrine [auto-injector] devices pursuant to this section shall use, 49 maintain and dispose of such devices pursuant to regulations of the 50 department. 51 (f) Nothing in this section shall require any eligible person or enti- 52 ty to acquire, possess, store, make available, or administer an epineph- 53 rine [auto-injector] device. 54 3. Prescriptions. (a) A health care practitioner who is authorized to 55 prescribe drugs may prescribe, dispense or provide an epinephrine [auto- 

 S. 7807 3 1 injector] device to or for an eligible person or entity by a non-pa- 2 tient-specific prescription. 3 (b) A pharmacist may dispense an epinephrine [auto-injector] device 4 pursuant to a non-patient-specific prescription under this subdivision. 5 (c) This subdivision does not limit any other authority a health care 6 practitioner or pharmacist has to prescribe, dispense, provide or admin- 7 ister an epinephrine [auto-injector] device. 8 4. Application of other laws. (a) Use of an epinephrine [auto-injec- 9 tor] device pursuant to this section shall be considered first aid or 10 emergency treatment for the purpose of any statute relating to liabil- 11 ity. 12 (b) Purchase, acquisition, possession or use of an epinephrine [auto- 13 injector] device pursuant to this section shall not constitute the 14 unlawful practice of a profession or other violation under title eight 15 of the education law or article thirty-three of this chapter. 16 (c) Any person otherwise authorized to sell or provide an epinephrine 17 [auto-injector] device may sell or provide it to a person or entity 18 authorized to possess it pursuant to this section. 19 § 2. Paragraph (f) of subdivision 2 of section 3000-c of the public 20 health law, as amended by chapter 22 of the laws of 2025, is amended to 21 read as follows: 22 (f) Nothing in this section shall require any eligible person or enti- 23 ty to acquire, possess, store, make available, or administer an epineph- 24 rine [auto-injector] device, except as provided for in subdivision 25 five-e of section two hundred twenty-five of this chapter. 26 § 3. Subdivision 2 of section 3000-a of the public health law, as 27 amended by chapter 373 of the laws of 2016, is amended to read as 28 follows: 29 2. (i) Any person or entity that purchases, operates, facilitates 30 implementation or makes available resuscitation equipment that facili- 31 tates first aid, an automated external defibrillator or an epinephrine 32 [auto-injector] device as required by or pursuant to law or local law, 33 or that conducts training under section three thousand-c of this arti- 34 cle, or (ii) an emergency health care provider under a collaborative 35 agreement pursuant to section three thousand-b of this article with 36 respect to an automated external defibrillator, or (iii) a health care 37 practitioner that prescribes, dispenses or provides an epinephrine 38 [auto-injector] device under section three thousand-c of this article, 39 shall not be liable for damages arising either from the use of that 40 equipment by a person who voluntarily and without expectation of mone- 41 tary compensation renders first aid or emergency treatment at the scene 42 of an accident or medical emergency, or from the use of defectively 43 manufactured equipment; provided that this subdivision shall not limit 44 the person's or entity's, the emergency health care provider's, or other 45 health care practitioner's liability for [his, her or its] their own 46 negligence, gross negligence or intentional misconduct. 47 § 4. Subdivision 5-e of section 225 of the public health law, as added 48 by chapter 461 of the laws of 2024 and as renumbered by chapter 22 of 49 the laws of 2025, is amended to read as follows: 50 5-e. Places of public assembly on-site epinephrine [auto-injector] 51 devices. 52 (a) Notwithstanding the provisions of paragraph (r) of subdivision 53 five of this section and section three thousand-c of this chapter, the 54 sanitary code shall provide that each place of public assembly as speci- 55 fied in this section shall be required to maintain and make available 56 on-site epinephrine [auto-injector] devices, as defined in paragraph (b) 

 S. 7807 4 1 of subdivision one of section three thousand-c of this chapter, in quan- 2 tities and types deemed by the commissioner to be adequate to ensure 3 ready and appropriate access for use during emergencies. 4 (b) Whenever places of public assembly are used for public or private 5 sponsored events or activities the owners, operators and administrators 6 responsible for such place of public assembly shall ensure the presence 7 of at least one staff person or volunteer who is trained, pursuant to 8 paragraph (c) of subdivision two of section three thousand-c of this 9 chapter, in the operation and use of an epinephrine [auto-injector] 10 device. 11 (c) For the purposes of this subdivision, "places of public assembly" 12 shall mean those with an occupancy capacity of at least one thousand 13 people and shall include: (i) all stadiums, ballparks, gymnasiums, field 14 houses, arenas, civic centers and similar facilities used for the 15 conduct of sporting events; and (ii) concert halls, recital halls, thea- 16 tres, indoor and outdoor amphitheaters or other auditoriums used for the 17 presentation of musical renditions or concerts. Places of public assem- 18 bly shall not include halls owned by churches, religious organizations, 19 granges, public associations, or free libraries as defined by section 20 two hundred fifty-three of the education law. 21 (d) Places of public assembly and staff pursuant to paragraphs (a) and 22 (b) of this subdivision shall be subject to the requirements and limita- 23 tions of section three thousand-c of this chapter. 24 (e) Pursuant to sections three thousand-a and three thousand-c of this 25 chapter, any public access epinephrine [auto-injector] device provider, 26 or any employee or other agent of the provider who, in accordance with 27 the provisions of this section, voluntarily and without expectation of 28 monetary compensation renders emergency medical or first aid treatment 29 using an epinephrine [auto-injector] device which has been made avail- 30 able pursuant to this section, to a person who is unconscious, ill or 31 injured, shall be liable only pursuant to section three thousand-a of 32 this chapter. 33 (f) Nothing in this subdivision shall be construed to prohibit a poli- 34 tical subdivision of the state from continuing to implement and enforce 35 any local law or regulation related to the placement of epinephrine 36 [auto-injector] devices in places of public assembly as defined in this 37 subdivision, in effect prior to the effective date of this subdivision. 38 Where a political subdivision has a local law in effect prior to the 39 effective date of this subdivision, the provisions of this subdivision 40 shall have no force and effect until such time as the political subdivi- 41 sion repeals its local law. 42 (g) (i) Operation of an epinephrine [auto-injector] device pursuant to 43 this section shall be considered first aid or emergency treatment for 44 the purpose of any statute relating to liability. 45 (ii) Operation of an epinephrine [auto-injector] device pursuant to 46 this section shall not constitute the unlawful practice of a profession 47 under title eight of the education law. 48 § 5. Subdivision 1 of section 902-b of the education law, as added by 49 chapter 423 of the laws of 2014, is amended to read as follows: 50 1. (a) Licensed nurses, nurse practitioners, physician assistants, or 51 physicians employed by schools are authorized to administer prescribed 52 epinephrine pursuant to the scope of practice of the licensed individual 53 under title VIII of this chapter, to pupils diagnosed by a physician or 54 other duly authorized health care provider with an allergy who have the 55 written permission of a physician or other duly authorized health care 56 provider for the administration of emergency epinephrine and written 

 S. 7807 5 1 parental consent to carry and use an epinephrine [auto injector] device 2 pursuant to section nine hundred sixteen-a of this article, during the 3 school day on school property and at any school function as such terms 4 are defined, respectively, by subdivisions one and two of section eleven 5 of this chapter. 6 (b) For the purposes of this subdivision, the term "epinephrine 7 device" shall have the same meaning as set forth in paragraph (b) of 8 subdivision one of section three thousand-c of the public health law. 9 § 6. Subdivision 1 of section 916-a of the education law, as added by 10 chapter 423 of the laws of 2014, is amended to read as follows: 11 1. (a) The board of education or trustees of each school district and 12 board of cooperative educational services shall allow pupils who have 13 been diagnosed by a physician or other duly authorized health care 14 provider with an allergy to carry and use a prescribed epinephrine [auto 15 injector] device for the emergency treatment of allergic reactions 16 during the school day on school property and at any school function as 17 such terms are defined, respectively, by subdivisions one and two of 18 section eleven of this chapter, with the written permission of a physi- 19 cian or other duly authorized health provider, and written parental 20 consent. The written permission shall include an attestation by the 21 physician or the health care provider confirming the following: [(a)](i) 22 the pupil's diagnosis of an allergy for which an epinephrine [auto 23 injector] device is needed; and [(b)] (ii) that the pupil has demon- 24 strated that [he or she] such pupil can self-administer the prescribed 25 epinephrine [auto injector] device effectively. The written permission 26 shall also include the circumstances which may warrant the use of the 27 epinephrine [auto injector] device. A record of such consent and 28 permission shall be maintained in the student's cumulative health 29 record. In addition, upon the written request of a parent or person in 30 parental relation, the board of education or trustees of a school 31 district and board of cooperative educational services shall allow such 32 pupils to maintain an extra epinephrine [auto injector] device for the 33 emergency treatment of allergies in the care and custody of a licensed 34 nurse, nurse practitioner, physician assistant, or physician employed by 35 such district or board of cooperative educational services, and shall be 36 readily accessible to such pupil. Nothing in this section shall require 37 a school district or board of cooperative educational services to retain 38 a licensed nurse, nurse practitioner, physician assistant, or physician 39 solely for the purpose of taking custody of a spare epinephrine [auto 40 injector] device for the emergency treatment of allergic reactions, or 41 require that a licensed nurse, nurse practitioner, physician assistant, 42 or physician be available at all times in a school building for taking 43 custody of the epinephrine [auto injector] device. In addition, the 44 epinephrine [auto injector] device provided by the pupil's parents or 45 persons in parental relation will be made available to the pupil as 46 needed in accordance with the school district's or board of cooperative 47 educational services' policy and the orders prescribed in the written 48 permission of the physician or other authorized health care provider. 49 (b) For the purposes of this subdivision, the term "epinephrine 50 device" shall have the same meaning as set forth in paragraph (b) of 51 subdivision one of section three thousand-c of the public health law. 52 § 7. Subdivision 1 of section 921 of the education law, as amended by 53 chapter 339 of the laws of 2021, is amended to read as follows: 54 1. (a) The board of education or trustees of each school district and 55 board of cooperative educational services and nonpublic schools are 56 authorized, but not obligated to have licensed registered professional 

 S. 7807 6 1 nurses, nurse practitioners, physician assistants, and physicians train 2 unlicensed school personnel to administer prescribed glucagon or 3 epinephrine [auto injectors] devices in emergency situations, where an 4 appropriately licensed health professional is not available, to pupils 5 who have the written permission of a physician or other duly authorized 6 health care provider for the administration of glucagon or an emergency 7 epinephrine [auto injector] device, along with written parental consent, 8 during the school day on school property and at any school function as 9 such terms are defined, respectively, by subdivisions one and two of 10 section eleven of this chapter. Training must be provided by a physician 11 or other duly authorized licensed health care professional in a compe- 12 tent manner and must be completed in a form and manner prescribed by the 13 commissioner in regulation. 14 (b) For the purposes of this subdivision, the term "epinephrine 15 device" shall have the same meaning as set forth in paragraph (b) of 16 subdivision one of section three thousand-c of the public health law. 17 § 8. Section 921-a of the education law, as amended by chapter 200 of 18 the laws of 2017, subdivision 3 as added by chapter 422 of the laws of 19 2023, is amended to read as follows: 20 § 921-a. On-site epinephrine [auto-injector] device. 1. School 21 districts, boards of cooperative educational services, county vocational 22 education and extension boards, charter schools, and non-public elemen- 23 tary and secondary schools in this state may provide and maintain 24 on-site in each instructional school facility epinephrine [auto-injec- 25 tors] devices in quantities and types deemed by the commissioner, in 26 consultation with the commissioner of health, to be adequate to ensure 27 ready and appropriate access for use during emergencies to any student 28 or staff having anaphylactic symptoms whether or not there is a previous 29 history of severe allergic reaction. 30 2. School districts, boards of cooperative educational services, coun- 31 ty vocational education and extension boards, charter schools, and non- 32 public elementary and secondary schools in this state, any person 33 employed by any such entity, or employed by a contractor of such an 34 entity while performing services for the entity may administer epineph- 35 rine [auto-injectors] devices in the event of an emergency pursuant to 36 the requirements of section three thousand-c of the public health law. 37 3. School districts, boards of cooperative educational services, coun- 38 ty vocational education and extension boards, charter schools, and non- 39 public elementary and secondary schools in this state that are author- 40 ized to provide and maintain epinephrine [auto-injectors] devices 41 on-site pursuant to this section shall provide all teachers with written 42 informational material on the use of an epinephrine [auto-injector] 43 device that has been created and approved by the commissioner of health. 44 4. For the purposes of this section, the term "epinephrine device" 45 shall have the same meaning as set forth in paragraph (b) of subdivision 46 one of section three thousand-c of the public health law. 47 § 9. This act shall take effect immediately; provided, however, that 48 sections two and four of this act shall take effect on the same date and 49 in the same manner as chapter 461 of the laws of 2024, as amended, takes 50 effect. 

Text of S 7807 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions
GovBuddy Demo

See how GovBuddy fits your team.

Share a few details and our team will follow up with a focused walkthrough.